Elute announced a strategic partnership with Spartan Medical, a Service-Disabled Veteran-Owned and operated medical solutions company serving the Department of Veterans Affairs (VA), Department of Defense (DoD), civilian hospitals, and Ambulatory Surgery Centers (ASCs) nationwide. This partnership will expand access of Elute’s BonVie+ bone graft substitute to physicians and patients at VA and DoD medical facilities worldwide.
BonVie+ calcium-salt resorbable bone void filler implant is used to fill bone defects, and with time, is replaced by new bone into the space previously occupied by the implant.
Spartan Medical is also leading a national campaign to raise awareness on the consequences of surgical site infections. BonVie+ complements Spartan’s efforts by providing a better solution to address suboptimal bone healing caused by infections.
“In a marketplace filled with fusion based biologics, the differentiation must be unique and solve real problems our surgeons are dealing with. BonVie+ creates an advantageous environment for complex orthopedic procedures…optimal resorption rate on the fusion side without seromas and wound drainage, which can complicate recovery, increase infection risk, and can interfere with implant or bone healing,” said Vince Proffitt, Founder & President of Spartan Medical.
Elute announced a strategic partnership with Spartan Medical, a Service-Disabled Veteran-Owned and operated medical solutions company serving the Department of Veterans Affairs (VA), Department of Defense (DoD), civilian hospitals, and Ambulatory Surgery Centers (ASCs) nationwide. This partnership will expand access of Elute's BonVie+ bone graft...
Elute announced a strategic partnership with Spartan Medical, a Service-Disabled Veteran-Owned and operated medical solutions company serving the Department of Veterans Affairs (VA), Department of Defense (DoD), civilian hospitals, and Ambulatory Surgery Centers (ASCs) nationwide. This partnership will expand access of Elute’s BonVie+ bone graft substitute to physicians and patients at VA and DoD medical facilities worldwide.
BonVie+ calcium-salt resorbable bone void filler implant is used to fill bone defects, and with time, is replaced by new bone into the space previously occupied by the implant.
Spartan Medical is also leading a national campaign to raise awareness on the consequences of surgical site infections. BonVie+ complements Spartan’s efforts by providing a better solution to address suboptimal bone healing caused by infections.
“In a marketplace filled with fusion based biologics, the differentiation must be unique and solve real problems our surgeons are dealing with. BonVie+ creates an advantageous environment for complex orthopedic procedures…optimal resorption rate on the fusion side without seromas and wound drainage, which can complicate recovery, increase infection risk, and can interfere with implant or bone healing,” said Vince Proffitt, Founder & President of Spartan Medical.
Copy to clipboard 
